Customer Login Support View Scan Gallery Talk to an Expert
Talk to an Expert
In the Media
July 31, 2025

First Of Its Kind AI-Powered Solution Fully Automates Blood Morphology

Scopio unveiled its groundbreaking Complete Blood Morphology (CBM) analyzer, bringing unprecedented scale, efficiency, and standardization to hematology.
Link to full article
In the Media
December 15, 2023

Nine revolutionary ways AI is advancing healthcare

Healthcare organizations and technology companies must work together to ensure responsible and ethical AI use and to explore the true benefits of AI.
Link to full article
In the Media
November 17, 2023

The Digital Age Of America’s Healthcare System Requires A Silicon Valley Approach

Earlier this year, Fast Company ranked Scopio Labs as the most innovative medical device company of 2023 for its development of an AI platform that automates the analysis of peripheral blood smear tests....
Link to full article
In the Media
October 06, 2023

Can Labs Go Remote? They Can With Digital Morphology

Across industries, the COVID-19 pandemic transformed how people view their workplaces. Among the lasting outcomes is a new cultural expectation that employees will stay home when sick to avoid transmitting...
Link to full article
In the Media
September 27, 2023

Top 10 uses of AI in healthcare

Here we digitally salute the Top 10 uses of AI in healthcare - from homes to hospitals, diagnosis to treatment, AI is enhancing patient care and efficiency. AI has been repeatedly touted as the answer to...
Link to full article
In the Media 2 mins
February 24, 2023

Meet Itai Hayut, CEO at Medical Device Company: Scopio Labs

Scopio Labs is a medical device company shaping the future of blood diagnostics. Scopio is the first to develop a completely digital end-to-end imaging and analysis platform for hematology testing.
Link to full article
In the Media 2 mins
January 26, 2023

Scopio on the future of telehematology

Through full-field digital cell morphology, Scopio Labs’ technology can automate the analysis of tens of thousands of cells at a time. This could mean bringing earlier detection and diagnosis of cancers,...
Link to full article
In the Media 6 mins
January 13, 2023

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer.

Itai Hayut, CEO of healthtech company Scopio Labs, on how AI & digitalisation help in the detection of blood related cancers, anaemia & allergies. Scopio Labs is a healthtech company that’s transforming cell...
Link to full article
In the Media 5 mins
November 06, 2022

Not under the microscope: Scopio Labs transforms blood testing

Co-founder & CEO Itai Hayut shares how his Israeli startup streamlines the hematologic diagnostic process while rendering blood lab microscopes obsolete.
Link to full article